- Home
- ICU vs IMCC Comparison
ICU vs IMCC Comparison
Compare ICU & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICU
- IMCC
- Stock Information
- Founded
- ICU 2018
- IMCC 1980
- Country
- ICU United States
- IMCC Israel
- Employees
- ICU N/A
- IMCC N/A
- Industry
- ICU Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- ICU Health Care
- IMCC Health Care
- Exchange
- ICU Nasdaq
- IMCC Nasdaq
- Market Cap
- ICU 10.4M
- IMCC 12.0M
- IPO Year
- ICU N/A
- IMCC N/A
- Fundamental
- Price
- ICU $0.61
- IMCC $2.95
- Analyst Decision
- ICU
- IMCC
- Analyst Count
- ICU 0
- IMCC 0
- Target Price
- ICU N/A
- IMCC N/A
- AVG Volume (30 Days)
- ICU 19.2M
- IMCC 148.9K
- Earning Date
- ICU 08-12-2025
- IMCC 08-13-2025
- Dividend Yield
- ICU N/A
- IMCC N/A
- EPS Growth
- ICU N/A
- IMCC N/A
- EPS
- ICU N/A
- IMCC N/A
- Revenue
- ICU $428,000.00
- IMCC $37,894,737.00
- Revenue This Year
- ICU $754.07
- IMCC $47.12
- Revenue Next Year
- ICU $100.09
- IMCC $12.83
- P/E Ratio
- ICU N/A
- IMCC N/A
- Revenue Growth
- ICU N/A
- IMCC 12.68
- 52 Week Low
- ICU $0.31
- IMCC $1.29
- 52 Week High
- ICU $9.56
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- ICU 41.48
- IMCC 51.60
- Support Level
- ICU $0.52
- IMCC $2.37
- Resistance Level
- ICU $0.83
- IMCC $3.75
- Average True Range (ATR)
- ICU 0.16
- IMCC 0.38
- MACD
- ICU 0.04
- IMCC 0.03
- Stochastic Oscillator
- ICU 50.89
- IMCC 41.99
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.